Structural analysis of the specificity of three neutralising human monoclonal antibodies against poliovirus

Abstract

Despite a global eradication programme, pathogenic polioviruses (PVs) still circulate, dictating a need for improved vaccines, therapeutics and diagnostics. Understanding their antigenic properties has been based largely on studies in mice. Here we study three human monoclonal antibodies specific for the native conformation and either PV1, 2 or 3, determining high-resolution structures of complexes with virus-like particles. The anti-PV1 and anti-PV2 Fabs bind around the icosahedral 3-fold axes, whilst the anti-PV3 Fab binds the canyon. We reveal the basis of serotype specificity and discrimination between native and expanded antigenic states. The anti-PV3 antibody partly penetrates the canyon and makes numerous serotype specific interactions on the south canyon face, distinguishing it from a pan-serotype and pan-antigenic state PV antibody. These structures show that human antibodies often span more than one classical antigenic site and can bind deeper crevices than murine antibodies, expanding our understanding of the antigenic landscape of PV capsids and potentially informing the design of better reagents, antivirals and vaccines against PV.

Neutralising antibodies and protection from progression to severe COVID-19: A meta-analysis
Karen M. Elias, Ainslie Mitchell, Eva Stadler +7
PLOS Medicine2 Sep 2026Peer-reviewedCC BY 4.0Full textImmunologyPLOS
Phenuivirus glycoprotein Gc domain is a conserved target of cross-functional monoclonal antibodies
D. Guerra, E. Cherubini, M. R. Echague +16
bioRxiv7 Oct 2026PreprintAll rights reservedFull textImmunologybioRxiv
Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial
Ming Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou +42
The Lancet HIV27 May 2026Peer-reviewedCC BY5 citedMicrobiologyOpenAlex
Cryo-EM and X-ray structures of an anti-MHC-I monoclonal antibody/H2-Kb complex reveal the basis of conformational dependence and allelic specificity
j. Jiang, K. Natarajan, R. Towler +4
bioRxiv11 Sep 2026PreprintCC0Full textImmunologybioRxiv
N1 neuraminidase monoclonal antibodies 2H08 and 3H03 have decreased binding and inhibition properties against H1N1 influenza viruses circulating after 2018
D. Bhavsar, E. Hermann, B. Monahan +4
bioRxiv26 Oct 2026PreprintCC BY-NC-NDFull textMicrobiologybioRxiv

Cite

BibTeX RIS

BibTeX

@article{bahar2026structural,
  title = {{Structural analysis of the specificity of three neutralising human monoclonal antibodies against poliovirus}},
  author = {Mohammad W. Bahar and Jessica J. Swanson and Daming Zhou and Rama D. Puligedda and Claudine Porta and Scott K. Dessain and Andrew J. Macadam and David J. Rowlands and Nicola J. Stonehouse and Elizabeth E. Fry and David I. Stuart},
  journal = {Communications Biology},
  year = {2026},
  month = nov,
  doi = {10.1038/s42003-026-11273-x},
  url = {https://www.nature.com/articles/s42003-026-11273-x},
  note = {CC BY 4.0},
}

RIS

TY  - JOUR
TI  - Structural analysis of the specificity of three neutralising human monoclonal antibodies against poliovirus
AU  - Mohammad W. Bahar
AU  - Jessica J. Swanson
AU  - Daming Zhou
AU  - Rama D. Puligedda
AU  - Claudine Porta
AU  - Scott K. Dessain
AU  - Andrew J. Macadam
AU  - David J. Rowlands
AU  - Nicola J. Stonehouse
AU  - Elizabeth E. Fry
AU  - David I. Stuart
PY  - 2026
DA  - 2026/11/03
JO  - Communications Biology
DO  - 10.1038/s42003-026-11273-x
UR  - https://www.nature.com/articles/s42003-026-11273-x
AB  - Despite a global eradication programme, pathogenic polioviruses (PVs) still circulate, dictating a need for improved vaccines, therapeutics and diagnostics. Understanding their antigenic properties has been based largely on studies in mice. Here we study three human monoclonal antibodies specific for the native conformation and either PV1, 2 or 3, determining high-resolution structures of complexes with virus-like particles. The anti-PV1 and anti-PV2 Fabs bind around the icosahedral 3-fold axes, whilst the anti-PV3 Fab binds the canyon. We reveal the basis of serotype specificity and discrimination between native and expanded antigenic states. The anti-PV3 antibody partly penetrates the canyon and makes numerous serotype specific interactions on the south canyon face, distinguishing it from a pan-serotype and pan-antigenic state PV antibody. These structures show that human antibodies often span more than one classical antigenic site and can bind deeper crevices than murine antibodies, expanding our understanding of the antigenic landscape of PV capsids and potentially informing the design of better reagents, antivirals and vaccines against PV.
SN  - 2399-3642
ER  -

Abstract

Related

Cite